Psychiatric Disorder Articles & Analysis: Older
12 news found
Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. Psychiatric drug development is a crucial aspect of mental health treatment, as it involves the development of ...
We believe we can provide a safer alternative to other THC products providing the benefits without the negative psychiatric side effects. Pre-clinical trials have demonstrated the reversal of depression-like and schizophrenia-related symptoms, blockage of memory impairment, hyperactive activity, and gene vulnerability. ...
Furthermore, Creative Diagnostics' services cover a variety of diseases, including cardiovascular diseases, oncology, inflammatory and autoimmune diseases, infectious diseases, and psychiatric disorders. Notably, it also provides assay development services for biomarkers, including proteins, nucleic acids, carbohydrates, and lipids, as well as building diagnostic ...
Beacon Biosignals, a startup that applies AI to EEG to unlock precision medicine for neurological and psychiatric disorders, presented research at the Alzheimer's Association International Conference, which took place July 31–Aug. 4, 2022, in San Diego. ...
Chadha is a medical doctor and internationally recognized expert in clinical pathology, neuroscience, neurological disease, and psychiatric disorders. She brings decades of global experience in clinical research and development, commercialization, patient engagement, and regulatory strategy. ...
EEG is standard of care in the clinical diagnosis and management of many neurologic diseases and sleep disorders, yet features of clinical significance often are difficult to extract from EEG data. ...
Furthermore, they are also fundamental players in the regulation of human health with regard to inflammation, infection, cancer, psychiatric disorders and neurological and immunological diseases,” says one of the senior scientists from Alfa Chemistry. ...
NeuroSigma, Inc., a Los Angeles-based bioelectronics company that is commercializing trigeminal nerve stimulation (TNS) technology to treat neurological and neuropsychiatric disorders, announced today that the following patents have issued or received notices of allowance in Canada and Japan: Canadian patent no. 2776694 entitled Devices, Systems, and Methods for Treatment of ...
About Lauren Sciences LLC Lauren Sciences was founded in New York, where launched business operations in 2012, licensed groundbreaking V-Smart™ platform nanotechnology from Ben-Gurion University in Israel, where launched R&D of innovative V-Smart™ targeted drug delivery platform, followed with development of proprietary pipeline of transformative V-Smart™ targeted ...
Licensed breakthrough V-SmartTM platform nanotechnology from Ben-Gurion University in Israel, where launched R&D of innovative V-SmartTM targeted drug delivery platform, followed by development of transformative V-SmartTM targeted therapeutics -- V-SmartTM Nanomedicines -- for CNS, neurodegenerative, rare/orphan brain diseases, neurodevelopmental/psychiatric ...
About Lauren Sciences LLC Lauren Sciences is a private, New York biotechnology company that leads in breakthrough innovation with the development of transformative V-Smart™ Nanomedicines for brain diseases, including CNS, neurodegenerative and rare/orphan brain diseases, such as GBM, NPC, ALS, Neuro-AIDS, Parkinson's, Alzheimer's and LSDs, among others, as well as neurodevelopmental and ...
They will jointly conduct research to understand design and application issues involved in the use of a dedicated MRI brain scanner to image for a range of neurological and psychiatric disorders such as stroke, Alzheimer’s Disease, Parkinson’s Disease, traumatic brain disorder (TBI), depression, and autism. ...
ByGE Power